Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont: Moving Beyond the “Blockbuster” Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach
HONG KONG, Apr 2, 2026 – (ACN Newswire) – Across the landscape of global biotech companies,…
Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum
Aurentis Capital Group Announces Technology-Driven Trading Platform for Global Markets
TMX Group Limited Completes Acquisition of RAFI Indices from Research Affiliates
Focus Graphite Chairman Converts Final C$835,000 Loan to Equity at a Premium to Market
Hong Kong emerges as top professional services platform for Mainland enterprises going global